• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

VICH Meeting Scheduled for May 25-27 in Washington, DC

FDA Veterinarian Newsletter January/February 2005 Volume XX, No I

The third International Cooperation on Harmonisation of Technical Requirements for the Registration of Veterinary Medicinal Products (VICH) Conference is scheduled for May 25 – 27, 2005, in Washington, DC.

It will be hosted by the U.S. delegation, which includes the Food and Drug Administration (FDA), the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service, and the Animal Health Institute, which represents the animal health industry.

VICH is an international program aimed at harmonizing the technical requirements for the registration or licensing of veterinary medicinal products. VICH was officially launched by regulatory and veterinary medicine industry officials representing Japan, the European Union, and the United States in April 1996.

The “VICH3” conference will focus on the numerous VICH guidelines that have been published in draft or final form during the last three years and will mark the closure of the first phase of the harmonization of regulatory requirements among the VICH participating regions.

Conference presenters will discuss the results of the VICH Expert Working Groups, including those on ecotoxichttp://wcms.fda.gov/ucm/resources/wcm/sitestudio/ity, biologicals quality monitoring, quality, safety, pharmacovigilance, antimicrobial resistance, and target animal safety. Members of the public will be able to comment on the VICH activities at this meeting.

VICH3 participants will also discuss the VICH strategy for future achievements in 2006-2010.

Dr. Lester Crawford, FDA Acting Commissioner, will open the conference, and keynote speaker Dr. Pedro Lichtinger, President of Pfizer Animal Health, will address the industry perspective on global trends in veterinary medicine.

More information about the program can be found at http://www.fda.gov/cvm/Documents/VICH_Conference_Program.pdf.